(Press-News.org) LOUISVILLE, Ky. – The largest genetic search for "obesity genes" in people of African ancestry has led to the discovery of three new regions of the human genome that influence obesity in these populations and others.
University of Louisville School of Public Health and Information Sciences Department of Epidemiology and Population Health researcher Kira Taylor, PhD, and her team today (April 14, 2013), published their findings in Nature Genetics.
The study involved more than 70,000 men and women of African ancestry, making it one of the largest genome-wide association studies. Within this population, researchers were able to identify three new common genetic variants, known as single nucleotide polymorphisms (SNPs), which are associated with body mass index (BMI) and obesity in the sample population. Also of significance, the study showed these genetic variants appear to affect BMI in the U.S. population among those with no known African ancestry. In addition, nearly all genetic variants previously identified as being linked to obesity in populations of European descent also were shown to influence BMI in this sample of African descent.
"A person who carries these variants may be predisposed to having higher BMI or becoming obese, but it is important to note these genes only account for a small percentage of higher BMI in the population," Taylor said. "We know environmental and behavioral factors like poor diet and lack of physical activity are the main reasons for obesity.
"Our discovery provides evidence that genes can influence obesity; it paves the way for examining rare genetic variants that are thought to be influential in common diseases such as obesity and cardiovascular disease."
Rare genetic variants can be identified through genome-wide DNA sequencing, a technique only recently becoming cost-effective and feasible for most researchers, she said.
In the future, this type of biological information could help predict who is at higher risk for obesity, therefore helping individuals become more aware of their need for prevention through diet and lifestyle choices. Personalized treatment through medication to reduce obesity could be another part of the equation.
###
Scientists from University of North Carolina at Chapel Hill, University of Southern California, Vanderbilt University and Broad Institute of Harvard and MIT, and several other institutions also were involved in the study, "A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry." It was funded in part through the National Institutes of Health.
Genetic discovery found to influence obesity in people of African ancestry
2013-04-15
ELSE PRESS RELEASES FROM THIS DATE:
Personalizing prostate specific antigen testing may improve specificity, reduce biopsies
2013-04-15
New York, NY, April 14, 2013 – Genetic variants have been identified which can increase serum prostate specific antigen (PSA) concentrations and prostate cancer risk. A new study published in The Journal of Urology® reports that correcting PSA levels for these genetic variants can have significant consequences, including avoiding unnecessary biopsies for some men and eliminating false complacency for others.
In this study of 964 healthy Caucasian men, correcting individual PSA levels for these genetic variants led to an 18.3 percent reduction in the number of men who ...
Stenting dramatically improves treatment access for dialysis patients
2013-04-15
NEW ORLEANS (April 15, 2013)—Kidney failure patients on dialysis derive long-term benefit from the minimally invasive placement of a stent that improves the function of dialysis access grafts, according to 12-month trial results being presented at the Society of Interventional Radiology's 38th Annual Scientific Meeting in New Orleans.
"Results of the study exceeded our expectations, and that is a boon for dialysis patients," said Ziv J Haskal, M.D., FSIR, lead author and professor of vascular and interventional radiology at the University of Maryland School of Medicine ...
Nonsurgical treatment turns back the clock, shrinks enlarged prostate
2013-04-15
NEW ORLEANS (April 15, 2013)—Men with a common condition that causes frequent nighttime trips to the bathroom can get relief with a minimally invasive treatment that shrinks the prostate, suggests a study being presented at the Society of Interventional Radiology's 38th Annual Scientific Meeting in New Orleans. The early findings hail from the first prospective U.S. trial of prostatic artery embolization (PAE), which reduces blood flow to the prostate, thus shrinking it.
"Nearly all men eventually suffer from an enlarged prostate as they age, and this treatment is almost ...
Laser liposuction melts fat, results in tighter skin
2013-04-15
NEW ORLEANS (April 15, 2013)—A new, minimally invasive treatment that uses lasers to melt fat could replace the "tummy tuck," suggests research on more than 2,000 people being presented at the Society of Interventional Radiology's 38th Annual Scientific Meeting in New Orleans.
Without the risks of a surgical procedure (such as the tummy tuck) and when used in combination with standard liposuction, the fat-melting action of laser lipolysis, a minimally invasive treatment, has the added benefit of producing new collagen (collagen is the main protein that gives the skin ...
JCI early table of contents for April 15, 2013
2013-04-15
Researchers untangle molecular pathology of giant axonal neuropathy
Giant axonal neuropathy (GAN) is a rare genetic disorder that causes central and peripheral nervous system dysfunction. GAN is known to be caused by mutations in the gigaxonin gene and is characterized by tangling and aggregation of neural projections, but the mechanistic link between the genetic mutation and the effects on neurons is unclear. In this issue of the Journal of Clinical Investigation, Robert Goldman and colleagues at Northwestern University uncover how mutations in gigaxonin contribute ...
Researchers untangle molecular pathology of giant axonal neuropathy
2013-04-15
Giant axonal neuropathy (GAN) is a rare genetic disorder that causes central and peripheral nervous system dysfunction. GAN is known to be caused by mutations in the gigaxonin gene and is characterized by tangling and aggregation of neural projections, but the mechanistic link between the genetic mutation and the effects on neurons is unclear. In this issue of the Journal of Clinical Investigation, Robert Goldman and colleagues at Northwestern University uncover how mutations in gigaxonin contribute to neural aggregation.They demonstrated that gigaxonin regulates the degradation ...
Resistance is futile: Researchers identify gene that mediates cisplatin resistance in ovarian cancer
2013-04-15
Platinum compounds, such as cisplatin and carboplatin, induce DNA cross-linking, prohibiting DNA synthesis and repair in rapidly dividing cells. They are first line therapeutics in the treatment of many solid tumors, but cancer cells frequently develop resistance to these drugs. Mechanisms of resistance typically include reduced platinum uptake and increased platinum export. In this issue of the Journal of Clinical Investigation, Anil Sood and colleagues at M.D. Anderson Cancer Center identified a cellular membrane protein, ATP11B, that mediates cisplatin resistance in ...
Smartphone way to lose weight
2013-04-15
Their study is the first to evaluate a smartphone app as the sole method for monitoring weight loss, with researchers creating My Meal Mate to trial against similar products for monitoring food intake, an online food diary and the traditional paper version.
The My Meal Mate app allows users to monitor their food intake and exercise, set a weight loss target and sends a weekly update on progress via text message. The smartphone app was used on average every other day in the trial, whilst the average use of the website and paper diary was about once a week. As a result, ...
C-peptide levels linked to death and heart disease in nondiabetic adults
2013-04-15
High blood levels of the serum C-peptide are linked to heart disease and death in people without diabetes, according to a large study published in CMAJ (Canadian Medical Association Journal).
Researchers looked at data from the Third Nutrition and Health Examination Survey (NHANES III) and the NHANES III Linked Mortality File to determine the link between C-peptide levels and death from all causes as well as from heart disease. They looked at mortality data on 5902 adults aged 40 years or older representative of the US population. People with high serum C-peptide levels ...
Preventing cognitive decline in healthy seniors
2013-04-15
Cognitive training exercises — or mental exercise — may help prevent cognitive decline in healthy older adults, while evidence for the benefits of pharmacologic substances and exercise is weak, outlines a review published in CMAJ (Canadian Medical Association Journal).
Mild cognitive impairment (cognitive decline that is more than normal for someone of a specific age) affects 10%-25% of people over age 70. The annual rate of decline to dementia (which is cognitive decline in several areas along with some functional ability) is about 10%. With an aging population, it is ...